Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients
Authors
Keywords
Aspirin, Triple negative, Estrogen receptor negative, Anti-platelet, Metastases
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 161, Issue 3, Pages 463-471
Publisher
Springer Nature
Online
2016-12-22
DOI
10.1007/s10549-016-4081-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Aspirin and Cancer
- (2016) Paola Patrignani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy
- (2014) Corbin D Jacobs et al. CANCER BIOLOGY & THERAPY
- Effects of aspirin on cancer initiation and progression
- (2013) Kevin S Choe et al. Expert Review of Anticancer Therapy
- Aspirin Use and the Risk of Prostate Cancer Mortality in Men Treated With Prostatectomy or Radiotherapy
- (2012) Kevin S. Choe et al. JOURNAL OF CLINICAL ONCOLOGY
- Coagulation and cancer: biological and clinical aspects
- (2012) A. FALANGA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The role of aspirin in cancer prevention
- (2012) Michael J. Thun et al. Nature Reviews Clinical Oncology
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hemostatic factors, innate immunity and malignancy
- (2012) Jay L. Degen et al. THROMBOSIS RESEARCH
- The relationship between tissue factor and cancer progression: insights from bench and bedside
- (2011) Y. W. van den Berg et al. BLOOD
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
- (2011) Myriam Labelle et al. CANCER CELL
- Aspirin Intake and Survival After Breast Cancer
- (2010) Michelle D. Holmes et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
- (2009) Carey K. Anders et al. Clinical Breast Cancer
- Prognosis of Patients with Triple-negative Breast Cancer and Brain Metastasis
- (2009) R. Venkitaraman et al. CLINICAL ONCOLOGY
- Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study
- (2009) Søren Friis et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Aspirin, salicylates, and cancer
- (2009) Peter C Elwood et al. LANCET
- Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer
- (2008) S. L. Hines et al. ANNALS OF ONCOLOGY
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer
- (2008) Nancy U. Lin et al. CANCER
- Triple-negative breast cancer
- (2008) Gert Stockmans et al. CURRENT OPINION IN ONCOLOGY
- NSAIDs and breast cancer: a possible prevention and treatment strategy
- (2008) A. Agrawal et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis
- (2008) B. Takkouche et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started